Prognostic and predictive value of serum carcinoembryonic antigen levels in advanced non-small cell lung cancer patients with epidermal growth factor receptor sensitive mutations and receiving tyrosine kinase inhibitors

BACKGROUND: Despite the widespread use of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) in advanced or recurrent non-small cell lung cancer (NSCLC), no biomarkers for predicting the efficacy of EGFR-TKIs in patients with EGFR-sensitive mutations have yet been identified....

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Xin Min, Zhao, Jing, Xing, Kai Lin, Sun, Si, Luo, Zhi Guo, Wang, Hui Jie, Wang, Jia Lei, Chang, Jian Hua, Wu, Xiang Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5642602/
https://www.ncbi.nlm.nih.gov/pubmed/29050327
http://dx.doi.org/10.18632/oncotarget.20145

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5642602/
https://www.ncbi.nlm.nih.gov/pubmed/29050327
http://dx.doi.org/10.18632/oncotarget.20145

Ejemplares similares